Close Menu

On the Decline

The Wall Street Journal's Health Blog has put together a chart of R&D spending by US drug companies — a related article in the paper said that R&D fell in 2009 by 3.8 percent to $382.6 billion. Pfizer and Johnson and Johnson's spending dropped by 10.8 and 12.7 percent, respectively while the other companies showed gains in spending.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.